Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China

被引:25
作者
Wei, Xin-su [1 ]
Wei, Chuan-dong [1 ]
Tong, Yong-qing [2 ]
Zhu, Cheng-liang [1 ]
Zhang, Ping-an [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430060, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Ctr Clin Mol Diag, Wuhan 430060, Hubei, Peoples R China
关键词
Hepatitis C virus; single nucleotide polymorphism; TLR7; TLR9; EVOLVING EPIDEMIOLOGY; INTERFERON; RECOGNITION; CELLS; TOLL-LIKE-RECEPTOR-7; EXPRESSION; VARIANTS; IMMUNITY; TLR7;
D O I
10.3349/ymj.2014.55.2.428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To analyze the correlation of polymorphisms of toll-like receptor 7 (TLR7) (rs179009) and toll-like receptor 9 (TLR9) (rs187084) in hepatitis C virus (HCV) infections in the Han population. Materials and Methods: The genotypes of TLR7IVS2-151 in HCV infection were detected by Sanger sequencing using polymerase chain reaction-restriction fragment length polymorphism to determine the TLR9 T-1486C single nucleotide polymorphisms (SNP) for all enrolled patients. Results: We found no significant difference between males with spontaneous clearance of HCV versus those chronically infected [chi(2)=2.71, p=0.10, odd ratios (OR)=0.58, 95% confidence interval (CI) 0.31-1.11]. However, significant differences were found for the distribution of TLR7 (rs179009) in females (chi(2)=9.46, p=0.01). In females, a significant difference was also found between chronic hepatitis C and those with spontaneous clearance of HCV in terms of TLR7 IVS2-151G/A allele frequencies (chi(2)=9.50, p=0.00, OR=0.46, 95% CI 0.28-0.75). In HCV-infected patients, no significant association was found between the frequency of TLR9 genotypes and alleles. Conclusion: The site of TLR7 IVS2-151 (rs179009) G/A may be a factor for susceptibility of chronic HCV in the female Han population. TLR9T-1486C (rs18084) SNP may not play a major role in HCV infection. However, individual risk profiles for HCV infection did vary by sex and this relationship should be further investigated.
引用
收藏
页码:428 / 434
页数:7
相关论文
共 36 条
[11]   The X-files in immunity: sex-based differences predispose immune responses [J].
Fish, Eleanor N. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (09) :737-744
[12]   Evasion of intracellular host defence by hepatitis C virus [J].
Gale, M ;
Foy, EM .
NATURE, 2005, 436 (7053) :939-945
[13]   Type 1 interferons and the virus-host relationship:: A lesson in detente [J].
García-Sastre, A ;
Biron, CA .
SCIENCE, 2006, 312 (5775) :879-882
[14]   Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 [J].
Heil, F ;
Hemmi, H ;
Hochrein, H ;
Ampenberger, F ;
Kirschning, C ;
Akira, S ;
Lipford, G ;
Wagner, H ;
Bauer, S .
SCIENCE, 2004, 303 (5663) :1526-1529
[15]   Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection [J].
Horsmans, Y ;
Berg, T ;
Desager, JP ;
Mueller, T ;
Schott, E ;
Fletcher, SP ;
Steffy, KR ;
Bauman, LA ;
Kerr, BM ;
Averett, DR .
HEPATOLOGY, 2005, 42 (03) :724-731
[16]  
Hu Kun, 2011, Zhonghua Yi Xue Za Zhi, V91, P1070
[17]   Interferon-α and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets [J].
Ito, T ;
Amakawa, R ;
Kaisho, T ;
Hemmi, H ;
Tajima, K ;
Uehira, K ;
Ozaki, Y ;
Tomizawa, H ;
Akira, S ;
Fukuhara, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (11) :1507-1512
[18]   Toll-like receptor control of the adaptive immune responses [J].
Iwasaki, A ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2004, 5 (10) :987-995
[19]   No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis [J].
Jaen, Olivier ;
Petit-Teixeira, Elisabeth ;
Kirsten, Holger ;
Ahnert, Peter ;
Semerano, Luca ;
Pierlot, Celine ;
Cornelis, Francois ;
Boissier, Marie-Christophe ;
Falgarone, Geraldine .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01)
[20]   Common variants of the TLR9 gene influence the clinical course of HBV infection [J].
Jia, Nina ;
Xie, Qing ;
Lin, Lanyi ;
Gui, Honglian ;
Wang, Hui ;
Jiang, Shan ;
Yu, Hong ;
Guo, Qing .
MOLECULAR MEDICINE REPORTS, 2009, 2 (02) :277-281